← Back to patent-cliff list
盐酸吡格列酮
Tier C — Watch / tradePioglitazone Hydrochloride
武田药品工业株式会社
Originator
1999
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PPARγ
Brand：Actos、艾可拓、Glustin
Indications (approved)：二型糖尿病
Regional status
US
批准上市
1999-07-15
EU
撤市
China
批准上市
2001-02-05
Japan
批准上市
1999-09-22
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Pioglitazone Hydrochloride?
Approved indications include: 二型糖尿病.
When does the Pioglitazone Hydrochloride patent expire?
No public expiry year is available for Pioglitazone Hydrochloride yet; this page updates once verified.
How do I get a quote for Pioglitazone Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25